CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-06 | Treco Douglas A Director | Purchase | +20,000 | $57.03 | $1.1M | 22,000 |
| 2025-07-16 | George Simeon Director | Purchase | +6,510 | $52.03 | $339K | 69,687 |
| 2025-07-16 | George Simeon Director | Purchase | +22,319 | $52.03 | $1.2M | 238,897 |
| 2025-07-16 | George Simeon Director | Purchase | +960,983 | $52.03 | $50.0M | 1,730,179 |
| 2025-04-03 | Patel Naimish Chief Medical Officer | Purchase | +1,508 | $32.96 | $50K | 1,508 |
| 2025-02-26 | Greene John Director | Purchase | +7,000 | $44.85 | $314K | 7,000 |
| 2016-10-24 | GLAXOSMITHKLINE PLC 10% owner | Purchase | +66,500 | $14.00 | $931K | 3,220,627 |
Page 1 of 1 · 7 trades